Investor Relations

Investor Relations

Corporate Profile

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“Lantheus”), which is a global leader in the development, distribution and commercialization of innovative diagnostic image agents and products. For 60 years, Lantheus has been dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. Our agents and products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging technologies.


NASDAQ | LNTH (Common Stock)

$12.15 + 0.25
Stock chart for: LNTH.O.  Currently trading at $12.15 with a 52 week high of $14.25 and a 52 week low of $1.82.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Recent News

03/13/17Lantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders
02/21/17Lantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance
02/21/17Lantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18
02/07/17Lantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time

Upcoming Events

There are currently no events scheduled.

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Lantheus Holdings, Inc. posts new information to the site. Just enter your e-mail address and click Submit.